Shopping Cart
- Remove All
- Your shopping cart is currently empty
Motapizone (NAT 05-239) is a selective PDE3 inhibitor that moderately reduces cytokine release in lipopolysaccharide (LPS)-stimulated alveolar macrophages and suppresses human platelet aggregation by elevating intracellular cAMP levels [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Motapizone (NAT 05-239) is a selective PDE3 inhibitor that moderately reduces cytokine release in lipopolysaccharide (LPS)-stimulated alveolar macrophages and suppresses human platelet aggregation by elevating intracellular cAMP levels [1] [2]. |
Molecular Weight | 260.32 |
Formula | C12H12N4OS |
Cas No. | 90697-57-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.